FOXO TECHNOLOGIES INC. Proceeds from Issuance or Sale of Equity
FOXO TECHNOLOGIES INC. (FOXO) reported Proceeds from Issuance or Sale of Equity of $3.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-09-30 was $0.00.
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-06-30 was $3.06M.
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for the quarter ending 2025-03-31 was $44.83K.
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for fiscal 2025 was $3.10M, a 3348.29% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. proceeds from issuance or sale of equity for fiscal 2024 was $89.92K.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $3.06M derived: sum of 3 quarters · filed 2026-08-14 | $3.10M 10-K · filed 2026-04-15 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.06M derived: sum of 2 quarters · filed 2026-08-14 | $3.10M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.10M 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $44.83K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $89.92K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |